Operating income increased 72.9%
Operating income changed +72.9% from the comparable as-filed period.
$638.3M→$1.1B3 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →ROST financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Operating margin moved 607 bp higher
Operating margin changed +607 basis points from the comparable as-filed period.
11.54%→17.62%3 prior comparisons
Net income increased 67.6%
Net income changed +67.6% from the comparable as-filed period.
$508.0M→$851.3M2 prior comparisons
Debt decreased 32.8%
Debt changed -32.8% from the comparable as-filed period.
$1.5B→$1.0B3 prior comparisons
Revenue increased 13.3%
Revenue changed +13.3% from the comparable as-filed period.
$5.5B→$6.3B3 prior comparisons
Cash & equivalents increased 11.5%
Cash & equivalents changed +11.5% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$3.8B→$4.3B2 prior comparisons
Inventory increased 18.4%
Inventory changed +18.4% from the comparable as-filed period.
$2.6B→$3.1B3 prior comparisons
Inventory / revenue moved 210 bp higher
Inventory / revenue changed +210 basis points from the comparable as-filed period.
47.18%→49.28%2 prior comparisons
Selling, general & administrative increased 14.3%
Selling, general & administrative changed +14.3% from the comparable as-filed period.
$888.7M→$1.0B3 prior comparisons
SBC / revenue moved 4 bp lower
SBC / revenue changed -4 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
0.79%→0.75%3 prior comparisons
Stock-based compensation increased 7.5%
Stock-based compensation changed +7.5% from the comparable as-filed period.
$43.9M→$47.3M3 prior comparisons
Operating margin increased by 1.21 points
Operating margin moved +1.21 percentage points from the comparable as-filed period.
12.17%→13.38%0 prior comparisons
Debt decreased 32.8%
Debt changed -32.8% from the comparable as-filed period.
$1.5B→$1.0B0 prior comparisons
Capital expenditure increased 0.8%
Capital expenditure changed +0.8% from the comparable as-filed period.
$207.4M→$209.0M0 prior comparisons
Free-cash-flow proxy increased 209.9%
Free-cash-flow proxy changed +209.9% from the comparable as-filed period.
$202.3M→$627.1M0 prior comparisons
Net income increased 35.6%
Net income changed +35.6% from the comparable as-filed period.
$479.2M→$650.0M0 prior comparisons
Operating cash flow increased 104.0%
Operating cash flow changed +104.0% from the comparable as-filed period.
$409.7M→$836.0M0 prior comparisons
Operating income increased 32.6%
Operating income changed +32.6% from the comparable as-filed period.
$606.5M→$804.0M0 prior comparisons
Revenue increased 20.6%
Revenue changed +20.6% from the comparable as-filed period.
$5.0B→$6.0B0 prior comparisons
Selling, general & administrative increased 22.4%
Selling, general & administrative changed +22.4% from the comparable as-filed period.
$797.1M→$975.9M0 prior comparisons
Stock-based compensation increased 50.4%
Stock-based compensation changed +50.4% from the comparable as-filed period.
$39.3M→$59.1M0 prior comparisons
Inventory increased 11.5%
Inventory changed +11.5% from the comparable as-filed period.
$2.7B→$3.0B0 prior comparisons
Capex / revenue decreased by 0.68 points
Capex / revenue moved -0.68 percentage points from the comparable as-filed period.
4.16%→3.48%0 prior comparisons
Cash & equivalents increased 9.2%
Cash & equivalents changed +9.2% from the comparable as-filed period.
$3.8B→$4.1B0 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.